LP Building Solutions today announced that it will release financial results for the fourth quarter and full year ended December 31, 2025, on Tuesday, Feb. 17, 2026. The company will host a live ...
LP Building Solutions announced the appointment of Kaycee Casteel as Vice President of Human Resources, effective immediately ...
Eli Lilly's gene-silencing drug lepodisiran has been shown to reduce lipoprotein(a) levels by more than 90% for at least six months with a single injection in a phase 2 trial, reinforcing its ...